Artes Medical - Worst Pharma Stocks of 2007

Company: Artes Medical
Starting stock price: $8.33
Ending stock price: $2.27
Percent Change: -72.75%

Details: Artes Medical develops and markets injectable products for cosmetic use by dermatologists and plastic surgeons. Its first product, ArteFill, won FDA approval in October 2006 and started shipping in 2007. It competes with collagen injections and Botox.

Artes Medical - Worst Pharma Stocks of 2007
Read more on

Suggested Articles

Perrigo is treading water in its specialty drugs reinvention plan. Could a merger with another struggling drugmaker—à la Pfizer and Mylan—be the cure?

AveXis' ex-CSO is "prepared to assert his rights and defend his conduct accordingly," a statement from a lawyer who recently represented Elon…

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.